APO Research
Talk to an analyst

APO RESEARCH · REPORT

Olaparib

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Olaparib Industry Growth and Trends Forecast to 2032

23 December 202577 pages

Choose your research edition.

Industry ResearchOlaparib Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Olaparib Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Olaparib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olaparib Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Olaparib Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Olaparib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Olaparib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Olaparib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Olaparib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Olaparib include AstraZeneca and Everest Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Olaparib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Olaparib market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Olaparib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Olaparib.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Olaparib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Olaparib Market by Company

AstraZeneca

Everest Pharmaceuticals

Olaparib Segment by Type

Tablets

Capsules

Olaparib Segment by Application

Ovarian Cancers

Prostate Cancers

Breast Cancers

Others

Olaparib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olaparib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olaparib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olaparib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Olaparib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Olaparib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablets Table 2. Major Company of Capsules Table 3. Global Olaparib Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Olaparib Sales by Type (2021-2026) & (k pcs) Table 5. Global Olaparib Sales Market Share in Volume by Type (2021-2026) Table 6. Global Olaparib Sales by Type (2021-2026) & (US$ Million) Table 7. Global Olaparib Sales Market Share in Value by Type (2021-2026) Table 8. Global Olaparib Price by Type (2021-2026) & (US$/pcs) Table 9. Global Olaparib Sales by Type (2027-2032) & (k pcs) Table 10. Global Olaparib Sales Market Share in Volume by Type (2027-2032) Table 11. Global Olaparib Sales by Type (2027-2032) & (US$ Million) Table 12. Global Olaparib Sales Market Share in Value by Type (2027-2032) Table 13. Global Olaparib Price by Type (2027-2032) & (US$/pcs) Table 14. North America Olaparib Sales by Type (2021-2026) & (k pcs) Table 15. North America Olaparib Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Olaparib Sales by Type (2021-2026) & (k pcs) Table 17. Europe Olaparib Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Olaparib Sales by Type (2021-2026) & (k pcs) Table 19. Asia-Pacific Olaparib Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Olaparib Sales by Type (2021-2026) & (k pcs) Table 21. Latin America Olaparib Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Olaparib Sales by Type (2021-2026) & (k pcs) Table 23. Middle East and Africa Olaparib Sales by Type (2021-2026) & (US$ Million) Table 24. Olaparib Industry Trends Table 25. Olaparib Industry Drivers Table 26. Olaparib Industry Opportunities and Challenges Table 27. Olaparib Industry Restraints Table 28. Global Olaparib Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Olaparib Revenue Market Share by Company (2021-2026) Table 30. Global Olaparib Sales by Company (2021-2026) & (k pcs) Table 31. Global Olaparib Sales Share by Company (2021-2026) Table 32. Global Olaparib Market Price by Company (2021-2026) & (US$/pcs) Table 33. Global Olaparib Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Olaparib Major Company Production Sites and Headquarters Table 35. Global Olaparib Company, Product Type & Application Table 36. Global Olaparib Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Olaparib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Olaparib Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Olaparib Sales by Region (2021-2026) & (k pcs) Table 41. Global Olaparib Sales Market Share in Volume by Region (2021-2026) Table 42. Global Olaparib Sales by Region (2021-2026) & (US$ Million) Table 43. Global Olaparib Sales Market Share in Value by Region (2021-2026) Table 44. Global Olaparib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 45. Global Olaparib Sales by Region (2027-2032) & (k pcs) Table 46. Global Olaparib Sales Market Share in Volume by Region (2027-2032) Table 47. Global Olaparib Sales by Region (2027-2032) & (US$ Million) Table 48. Global Olaparib Sales Market Share in Value by Region (2027-2032) Table 49. Global Olaparib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 50. Global Olaparib Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Olaparib Sales by Application (2021-2026) & (k pcs) Table 52. Global Olaparib Sales Market Share in Volume by Application (2021-2026) Table 53. Global Olaparib Sales by Application (2021-2026) & (US$ Million) Table 54. Global Olaparib Sales Market Share in Value by Application (2021-2026) Table 55. Global Olaparib Price by Application (2021-2026) & (US$/pcs) Table 56. Global Olaparib Sales by Application (2027-2032) & (k pcs) Table 57. Global Olaparib Sales Market Share in Volume by Application (2027-2032) Table 58. Global Olaparib Sales by Application (2027-2032) & (US$ Million) Table 59. Global Olaparib Sales Market Share in Value by Application (2027-2032) Table 60. Global Olaparib Price by Application (2027-2032) & (US$/pcs) Table 61. North America Olaparib Sales by Application (2021-2026) & (k pcs) Table 62. North America Olaparib Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Olaparib Sales by Application (2021-2026) & (k pcs) Table 64. Europe Olaparib Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Olaparib Sales by Application (2021-2026) & (k pcs) Table 66. Asia-Pacific Olaparib Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Olaparib Sales by Application (2021-2026) & (k pcs) Table 68. Latin America Olaparib Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Olaparib Sales by Application (2021-2026) & (k pcs) Table 70. Middle East and Africa Olaparib Sales by Application (2021-2026) & (US$ Million) Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Olaparib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. AstraZeneca Olaparib Product Portfolio Table 75. AstraZeneca Recent Development Table 76. Everest Pharmaceuticals Company Information Table 77. Everest Pharmaceuticals Business Overview Table 78. Everest Pharmaceuticals Olaparib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. Everest Pharmaceuticals Olaparib Product Portfolio Table 80. Everest Pharmaceuticals Recent Development Table 81. North America Olaparib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 82. North America Olaparib Sales by Country (2021-2026) & (k pcs) Table 83. North America Olaparib Sales Market Share by Country (2021-2026) Table 84. North America Olaparib Sales Forecast by Country (2027-2032) & (k pcs) Table 85. North America Olaparib Sales Market Share Forecast by Country (2027-2032) Table 86. North America Olaparib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Olaparib Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Olaparib Market Share by Country (2021-2026) Table 89. North America Olaparib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Olaparib Market Share Forecast by Country (2027-2032) Table 91. Europe Olaparib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 92. Europe Olaparib Sales by Country (2021-2026) & (k pcs) Table 93. Europe Olaparib Sales Market Share by Country (2021-2026) Table 94. Europe Olaparib Sales Forecast by Country (2027-2032) & (k pcs) Table 95. Europe Olaparib Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Olaparib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Olaparib Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Olaparib Market Share by Country (2021-2026) Table 99. Europe Olaparib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Olaparib Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Olaparib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Olaparib Sales by Country (2021-2026) & (k pcs) Table 103. Asia-Pacific Olaparib Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Olaparib Sales Forecast by Country (2027-2032) & (k pcs) Table 105. Asia-Pacific Olaparib Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Olaparib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Olaparib Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Olaparib Market Share by Country (2021-2026) Table 109. Asia-Pacific Olaparib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Olaparib Market Share Forecast by Country (2027-2032) Table 111. Latin America Olaparib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 112. Latin America Olaparib Sales by Country (2021-2026) & (k pcs) Table 113. Latin America Olaparib Sales Market Share by Country (2021-2026) Table 114. Latin America Olaparib Sales Forecast by Country (2027-2032) & (k pcs) Table 115. Latin America Olaparib Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Olaparib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Olaparib Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Olaparib Market Share by Country (2021-2026) Table 119. Latin America Olaparib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Olaparib Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Olaparib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Olaparib Sales by Country (2021-2026) & (k pcs) Table 123. Middle East and Africa Olaparib Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Olaparib Sales Forecast by Country (2027-2032) & (k pcs) Table 125. Middle East and Africa Olaparib Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Olaparib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Olaparib Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Olaparib Market Share by Country (2021-2026) Table 129. Middle East and Africa Olaparib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Olaparib Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Olaparib Distributors List Table 134. Olaparib Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Olaparib Image Figure 2. Global Olaparib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Olaparib Market Size (2021-2032) & (US$ Million) Figure 4. Global Olaparib Sales (2021-2032) & (k pcs) Figure 5. Tablets Image Figure 6. Global Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 7. Capsules Image Figure 8. Global Capsules Sales YoY Growth (2021-2032) & (k pcs) Figure 9. Global Olaparib Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Olaparib Market Share by Type 2025 VS 2032 Figure 11. North America Olaparib Sales Market Share in Volume by Type in 2025 Figure 12. North America Olaparib Sales Market Share in Value by Type in 2025 Figure 13. Europe Olaparib Sales Market Share in Volume by Type in 2025 Figure 14. Europe Olaparib Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Olaparib Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Olaparib Sales Market Share in Value by Type in 2025 Figure 17. Latin America Olaparib Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Olaparib Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Olaparib Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Olaparib Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Olaparib Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Ovarian Cancers Image Figure 24. Global Ovarian Cancers Sales YoY Growth (2021-2032) & (k pcs) Figure 25. Prostate Cancers Image Figure 26. Global Prostate Cancers Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Breast Cancers Image Figure 28. Global Breast Cancers Sales YoY Growth (2021-2032) & (k pcs) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 31. Global Olaparib Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Olaparib Market Share by Application 2025 VS 2032 Figure 33. North America Olaparib Sales Market Share in Volume by Application in 2025 Figure 34. North America Olaparib Sales Market Share in Value by Application in 2025 Figure 35. Europe Olaparib Sales Market Share in Volume by Application in 2025 Figure 36. Europe Olaparib Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Olaparib Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Olaparib Sales Market Share in Value by Application in 2025 Figure 39. Latin America Olaparib Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Olaparib Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Olaparib Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Olaparib Sales Market Share in Value by Application in 2025 Figure 43. North America Olaparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 44. North America Olaparib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Olaparib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Olaparib Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Olaparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 48. Europe Olaparib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Olaparib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Olaparib Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Olaparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 52. Asia-Pacific Olaparib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Olaparib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Olaparib Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Olaparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 56. Latin America Olaparib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Olaparib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Olaparib Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Olaparib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 60. Middle East and Africa Olaparib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Olaparib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Olaparib Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Olaparib Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Olaparib Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Ovarian Cancers
  • Prostate Cancers
  • Breast Cancers
  • Others
Companies covered
  • AstraZeneca
  • Everest Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Olaparib Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Olaparib Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Olaparib Market by Type
  6. 1.3.1 Tablets
  7. 1.3.2 Capsules
  8. 1.4 Global Olaparib Market Size by Type
  9. 1.4.1 Global Olaparib Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Olaparib Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Olaparib Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Olaparib Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Olaparib Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Olaparib Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Olaparib Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Olaparib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Olaparib Industry Trends
  2. 2.2 Olaparib Industry Drivers
  3. 2.3 Olaparib Industry Opportunities and Challenges
  4. 2.4 Olaparib Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Olaparib Revenue (2021-2026)
  2. 3.2 Global Top Players by Olaparib Sales (2021-2026)
  3. 3.3 Global Top Players by Olaparib Price (2021-2026)
  4. 3.4 Global Olaparib Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Olaparib Major Company Production Sites & Headquarters
  6. 3.6 Global Olaparib Company, Product Type & Application
  7. 3.7 Global Olaparib Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Olaparib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Olaparib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Olaparib Tier 1, Tier 2, and Tier 3
4 Olaparib Regional Status and Outlook
  1. 4.1 Global Olaparib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Olaparib Historic Market Size by Region
  3. 4.2.1 Global Olaparib Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Olaparib Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Olaparib Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Olaparib Forecasted Market Size by Region
  7. 4.3.1 Global Olaparib Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Olaparib Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Olaparib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Olaparib by Application
  1. 5.1 Olaparib Market by Application
  2. 5.1.1 Ovarian Cancers
  3. 5.1.2 Prostate Cancers
  4. 5.1.3 Breast Cancers
  5. 5.1.4 Others
  6. 5.2 Global Olaparib Market Size by Application
  7. 5.2.1 Global Olaparib Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Olaparib Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Olaparib Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Olaparib Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Olaparib Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Olaparib Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Olaparib Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Olaparib Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Olaparib Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Olaparib Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Everest Pharmaceuticals
  8. 6.2.1 Everest Pharmaceuticals Company Information
  9. 6.2.2 Everest Pharmaceuticals Business Overview
  10. 6.2.3 Everest Pharmaceuticals Olaparib Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Everest Pharmaceuticals Olaparib Product Portfolio
  12. 6.2.5 Everest Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Olaparib Sales by Country
  2. 7.1.1 North America Olaparib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Olaparib Sales by Country (2021-2026)
  4. 7.1.3 North America Olaparib Sales Forecast by Country (2027-2032)
  5. 7.2 North America Olaparib Market Size by Country
  6. 7.2.1 North America Olaparib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Olaparib Market Size by Country (2021-2026)
  8. 7.2.3 North America Olaparib Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Olaparib Sales by Country
  2. 8.1.1 Europe Olaparib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Olaparib Sales by Country (2021-2026)
  4. 8.1.3 Europe Olaparib Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Olaparib Market Size by Country
  6. 8.2.1 Europe Olaparib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Olaparib Market Size by Country (2021-2026)
  8. 8.2.3 Europe Olaparib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Olaparib Sales by Country
  2. 9.1.1 Asia-Pacific Olaparib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Olaparib Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Olaparib Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Olaparib Market Size by Country
  6. 9.2.1 Asia-Pacific Olaparib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Olaparib Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Olaparib Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Olaparib Sales by Country
  2. 10.1.1 South America Olaparib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Olaparib Sales by Country (2021-2026)
  4. 10.1.3 South America Olaparib Sales Forecast by Country (2027-2032)
  5. 10.2 South America Olaparib Market Size by Country
  6. 10.2.1 South America Olaparib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Olaparib Market Size by Country (2021-2026)
  8. 10.2.3 South America Olaparib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Olaparib Sales by Country
  2. 11.1.1 Middle East and Africa Olaparib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Olaparib Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Olaparib Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Olaparib Market Size by Country
  6. 11.2.1 Middle East and Africa Olaparib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Olaparib Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Olaparib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Olaparib Value Chain Analysis
  2. 12.1.1 Olaparib Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Olaparib Production Mode & Process
  7. 12.2 Olaparib Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Olaparib Distributors
  10. 12.2.3 Olaparib Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst